Berko
- Company typePrivate
- Founded1973
- HeadquartersAlasehir
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Berko firmographics
Firmographics- Name
- Berko
- Legal name
- Berko İlaç ve Kimya Sanayi A.Ş.
- Website
- https://berkoilac.com.tr
- Company type
- Private
- Founded year
- 1973
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Berko industry classification
Industry- Product category
- Generic Pharmaceuticals Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
- akta.pro secondary industries
- Respiratory & Allergy Pharmaceuticals (HLAIAAAH), Specialty & Functional Packaged Foods (Gluten-Free, Keto, Organic, Medical/Allergen-Friendly) (CRADAAAI)
Keywords
Where Berko is headquartered
LocationHeadquarters
- HQ city
- Alasehir
Offices13 records
Markets served
Berko business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Products Sales: Berko İlaç generates revenue through the manufacture and sale of generic pharmaceutical products including vitamins, minerals, dermatologicals, respiratory medications, and food supplements to the Turkish market and for export.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Berko product offering
Product offeringCore offering
Berko İlaç manufactures and markets a comprehensive portfolio of generic pharmaceutical products — including vitamins, minerals, iron and zinc supplements, dermatologicals, respiratory and anti-infective medications, food supplements, and topical anti-inflammatories — across multiple dosage forms (tablets, capsules, syrups, suspensions, creams, sprays, drops, injectables). Products are sold to pharmacies and healthcare professionals across Turkey through a direct field sales organization and exported to 23–26 international markets from EU GMP-certified facilities in Istanbul.
Product overview
Berko İlaç ve Kimya Sanayi A.Ş. is a Turkish pharmaceutical company with 41 years of experience producing and marketing a comprehensive portfolio of pharmaceutical products and food supplements. The product portfolio includes multiple branded product lines: ZINCO (zinc supplements in various formulations including syrups, capsules, drops, and combination products with vitamins), ZINCOMEGA (omega-3 and multivitamin supplements), FERIFER (iron supplements), FERROZINC (iron and zinc combinations), DESİFEROL (vitamin D products), IBURAMIN (cold and flu medications), DROPOLEV (cough treatments), KETOBER (topical anti-inflammatory products), antibiotics, dermatologicals, and numerous other therapeutic categories. Manufacturing capabilities include GMP-certified facilities producing tablets, capsules, syrups, suspensions, creams, sprays, drops, and injectables with annual capacity exceeding 110 million boxes. The company expanded into a new entity, Berat Beran İlaç, in 2024 for specialty products in pediatrics, physical therapy, emergency, and internal medicine.
Differentiator
Problem solved
Functional benefit
Brands
- Beran Pharmacy (historical): The original pharmacy founded by Berat Beran in 1973, which later evolved into Beran Laboratory and then Berko Pharmaceuticals.
- Berko Children's Theatre
- Berko Kariyer
- Sağlıklı Yarınlara
Products and services
- ZINCO Product Line ZINCO brand encompasses zinc supplements in multiple formulations: Zinco 30 mg Forte Syrup (100 ml), Zinco 50 mg Hard Capsules, Zinco Drops with herbal oils, Zinco Syrup (15 mg/5 ml), Zinco-C Film Tablets with Vitamin C, Zinco-C Syrup, Zinco-K 15 mg/5 ml Syrup, Zinco-C Plus Capsules (Vitamin C, D, Zinc), and Zinco-C Plus Syrup. Distributed to pharmacies for consumer patients with zinc deficiency or immune support needs.
- ZINCOMEGA Product Line
Quantifiable outcome
- Reached 142 million boxes annual production capacity
- +1 more outcomes
Companies that use Berko
Customer profileSegments1 record
Ideal customer profiles2 records
Berko technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Berko partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Dong-A STcoreStrategic collaboration signed at CPHI Worldwide 2023 for Type II Diabetes products and fixed dose combinations. Technology transfer to Berko Manufacturing Facility planned for original products in chronic disease treatment category.
- Orphamed PharmacoreStrategic collaboration signed at CPHI Worldwide 2023 alongside Dong-A ST for Type II Diabetes treatment products and fixed dose combinations.
- Atatürk UniversitycoreIndustry-university collaboration for Research Universities Support Programme (YÖK). Project titled 'Synthesis of Remifentanil and Fentanyl Active Ingredients and Derivatives through Effective and New Methods' conducted with Associate Professor Bilal Nişancı.
- May PharmaminorPartner in the Remifentanil and Fentanyl synthesis project alongside Atatürk University.
- Altobio PharmaceuticalsminorPartner in the Remifentanil and Fentanyl synthesis project alongside Atatürk University.
- Make-A-Wish Türkiye DerneğiminorCollaboration for Yılbaşı Ağacı (Christmas Tree) project bringing gifts to Dilek Çocukları (Wish Children) with life-threatening illnesses.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Berko competitors and assessment
Company assessmentBroad incumbents
- Krka: European-headquartered generic pharmaceutical manufacturer with strong CEE/CIS presence and own R&D. Comparable as a privately controlled, vertically integrated generics producer exporting to multiple geographies, including Turkey and nearby markets.
- Sandoz: Global generic and biosimilar leader with broad manufacturing and distribution capabilities. Comparable as a generic pharmaceutical manufacturer at scale, though much larger and more diversified geographically than Berko.
- Teva Pharmaceutical: World's largest generic pharmaceutical manufacturer with extensive portfolio and global manufacturing footprint. Comparable as a broad-line generics producer serving pharmacy and institutional channels, though at materially greater scale than Berko.
Direct peers
- Bilim İlaç: Leading Turkish generic pharmaceutical producer operating manufacturing facilities and a national sales force across multiple therapeutic categories including respiratory and dermatology. Comparable to Berko on product breadth, manufacturing footprint and domestic field sales.
- Atabay İlaç: Turkish pharmaceutical manufacturer with API and finished dosage form production, exporting to multiple geographies. Comparable as a privately held Turkish pharma with GMP-certified manufacturing and export orientation.
- Nobel İlaç: Privately held Turkish pharmaceutical manufacturer with a broad generic portfolio across multiple therapeutic areas and an established domestic sales force. Closely comparable on therapeutic coverage, manufacturing scale and channel strategy.
- Abdi İbrahim: Turkey's largest domestic pharmaceutical manufacturer with a broad generic and specialty portfolio, nationwide field-sales coverage and exports to 50+ countries. Directly comparable to Berko as a Turkish-headquartered generic manufacturer targeting pharmacy and institutional channels.
- İlko İlaç: Turkish pharmaceutical manufacturer focused on generic and biosimilar products with R&D capabilities. Comparable on the generic-plus-specialty manufacturing model and R&D-driven positioning.
- Eczacıbaşı İlaç (EİP): Major Turkish generic pharmaceutical producer with branded generics and OTC products, operating GMP manufacturing facilities and an extensive domestic distribution network. Directly comparable on product categories, GTM model and Turkish-market focus.
- Deva İlaç: Turkish pharmaceutical manufacturer with a broad generics portfolio, GMP-certified production sites and export operations. Comparable on product categories, regulatory positioning, and channel mix across domestic and export markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Berko social profiles
Digital presenceBerko compliance and trust
Trust signalCompliance1 record
Berko financial estimates
Financial estimateRevenue estimate
Valuation estimate
Berko leadership team
Management profileNumber of profiles
Profiles1 record
Berko subsidiaries and ownership
Company hierarchySubsidiaries1 record
Berko funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Berko M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Berko
What does Berko do?
Berko İlaç manufactures and markets a comprehensive portfolio of generic pharmaceutical products — including vitamins, minerals, iron and zinc supplements, dermatologicals, respiratory and anti-infective medications, food supplements, and topical anti-inflammatories — across multiple dosage forms (tablets, capsules, syrups, suspensions, creams, sprays, drops, injectables). Products are sold to pharmacies and healthcare professionals across Turkey through a direct field sales organization and exported to 23–26 international markets from EU GMP-certified facilities in Istanbul.
Is Berko a public or private company?
Berko is a private company. It is classified as family owned and is currently operating.
When was Berko founded?
Berko was founded in 1973. It employs 501 to 1,000 people.
Where is Berko based?
Berko is headquartered in Alasehir.
How does Berko make money?
One revenue line is on record: pharmaceutical Products Sales.
Who are Berko's main competitors?
Broad incumbents on record are Krka, Sandoz and Teva Pharmaceutical. Direct peers are Bilim İlaç, Atabay İlaç, Nobel İlaç, Abdi İbrahim, İlko İlaç, Eczacıbaşı İlaç (EİP) and Deva İlaç.
Does Berko have an API?
No public API is recorded for Berko.
What industry is Berko in?
Berko's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAAAH, Respiratory & Allergy Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.